Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients

Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients

Abstract Objective The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients. Background Hepatocellular carcinoma (HCC) continues to be a serious disease burden. Interferon Induced Transmembrane protein 3 (IFITM3) is a protein that encoded in humans b...

Full description

Bibliographic Details
Main Authors: Rania M. Bondok, Lamiaa A. Barakat, Alyaa R. Elsergany, Nancy Mahsoub, Maivel H. Ghattas
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cancer
Subjects:
Interferon-Induced transmembrane protein 3
Hepatocellular carcinoma
Hepatitis C virus
Gene polymorphism
Online Access:https://doi.org/10.1186/s12885-023-11071-2

Internet

https://doi.org/10.1186/s12885-023-11071-2

Similar Items